These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11775847)

  • 21. Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia.
    Steullet P; Neijt HC; Cuénod M; Do KQ
    Neuroscience; 2006 Feb; 137(3):807-19. PubMed ID: 16330153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calcium channels associated with glutamate receptors].
    Ogita K; Kuramoto N; Yoneda Y
    Nihon Rinsho; 1998 Jul; 56(7):1819-23. PubMed ID: 9702059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function.
    Madry C; Mesic I; Bartholomäus I; Nicke A; Betz H; Laube B
    Biochem Biophys Res Commun; 2007 Mar; 354(1):102-8. PubMed ID: 17214961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of agmatine on heteromeric N-methyl-D-aspartate receptor channels.
    Askalany AR; Yamakura T; Petrenko AB; Kohno T; Sakimura K; Baba H
    Neurosci Res; 2005 Aug; 52(4):387-92. PubMed ID: 15982768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NMDA type glutamate receptors expressed by primary rat osteoblasts have the same electrophysiological characteristics as neuronal receptors.
    Gu Y; Genever PG; Skerry TM; Publicover SJ
    Calcif Tissue Int; 2002 Mar; 70(3):194-203. PubMed ID: 11907717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D(1) and D(3) receptors oppositely regulate NMDA- and cocaine-induced MAPK signaling via NMDA receptor phosphorylation.
    Jiao H; Zhang L; Gao F; Lou D; Zhang J; Xu M
    J Neurochem; 2007 Oct; 103(2):840-8. PubMed ID: 17897358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The NMDA receptor complex: a long and winding road to therapeutics.
    Wood PL
    IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
    Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux.
    Vissel B; Krupp JJ; Heinemann SF; Westbrook GL
    Nat Neurosci; 2001 Jun; 4(6):587-96. PubMed ID: 11369939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptor subunits.
    Domingues A; Almeida S; da Cruz e Silva EF; Oliveira CR; Rego AC
    Neurochem Int; 2007 May; 50(6):872-80. PubMed ID: 17403555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner.
    Masuko T; Suzuki I; Kizawa Y; Kusama-Eguchi K; Watanabe K; Kashiwagi K; Igarashi K; Kusama T
    Neurosci Lett; 2004 Nov; 371(1):30-3. PubMed ID: 15500961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum.
    Schotanus SM; Chergui K
    J Neurochem; 2008 Aug; 106(4):1758-65. PubMed ID: 18540994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
    Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
    J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs.
    Barton ME; White HS; Wilcox KS
    Epilepsy Res; 2004 Mar; 59(1):13-24. PubMed ID: 15135163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modulation of NMDA-receptor efficiency by intracellular agents].
    Bazhenov AV; Murzina GB; Kleshchevnikov AM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(5):733-49. PubMed ID: 10570528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The NMDA receptor complex.
    Scatton B
    Fundam Clin Pharmacol; 1993; 7(8):389-400. PubMed ID: 8294079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of NMDA receptors by ethanol.
    Kumari M; Ticku MK
    Prog Drug Res; 2000; 54():152-89. PubMed ID: 10857388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.
    Mony L; Kew JN; Gunthorpe MJ; Paoletti P
    Br J Pharmacol; 2009 Aug; 157(8):1301-17. PubMed ID: 19594762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuromodulation by Mg2+ and polyamines of excitatory amino acid currents in rodent neurones in culture.
    Kumamoto E
    Magnes Res; 1996 Dec; 9(4):317-27. PubMed ID: 9247881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allosteric modulation of N-methyl-D-aspartate receptors.
    Reynolds IJ; Miller RJ
    Adv Pharmacol; 1990; 21():101-26. PubMed ID: 2148268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.